Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Oscar Health (OSCR) Competitors

Oscar Health logo
$22.67 +0.53 (+2.38%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$22.53 -0.14 (-0.61%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OSCR vs. WTW, PFG, AEG, BNT, and EG

Should you buy Oscar Health stock or one of its competitors? MarketBeat compares Oscar Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oscar Health include Willis Towers Watson Public (WTW), Principal Financial Group (PFG), Aegon (AEG), Brookfield Wealth Solutions (BNT), and Everest Group (EG). These companies are all part of the "insurance" industry.

How does Oscar Health compare to Willis Towers Watson Public?

Oscar Health (NYSE:OSCR) and Willis Towers Watson Public (NASDAQ:WTW) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 93.1% of Willis Towers Watson Public shares are owned by institutional investors. 24.4% of Oscar Health shares are owned by insiders. Comparatively, 0.4% of Willis Towers Watson Public shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Oscar Health has a beta of 2.34, indicating that its share price is 134% more volatile than the broader market. Comparatively, Willis Towers Watson Public has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

In the previous week, Willis Towers Watson Public had 6 more articles in the media than Oscar Health. MarketBeat recorded 16 mentions for Willis Towers Watson Public and 10 mentions for Oscar Health. Oscar Health's average media sentiment score of 0.58 beat Willis Towers Watson Public's score of 0.16 indicating that Oscar Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
3 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Willis Towers Watson Public
4 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Willis Towers Watson Public has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Willis Towers Watson Public, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.58-$443.15M-$0.59N/A
Willis Towers Watson Public$9.71B2.50$1.61B$17.1515.01

Willis Towers Watson Public has a net margin of 16.84% compared to Oscar Health's net margin of -0.30%. Willis Towers Watson Public's return on equity of 21.52% beat Oscar Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health-0.30% -3.26% -0.57%
Willis Towers Watson Public 16.84%21.52%6.00%

Oscar Health presently has a consensus price target of $18.22, indicating a potential downside of 19.61%. Willis Towers Watson Public has a consensus price target of $351.73, indicating a potential upside of 36.65%. Given Willis Towers Watson Public's stronger consensus rating and higher possible upside, analysts clearly believe Willis Towers Watson Public is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17
Willis Towers Watson Public
0 Sell rating(s)
6 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
2.76

Summary

Willis Towers Watson Public beats Oscar Health on 13 of the 17 factors compared between the two stocks.

How does Oscar Health compare to Principal Financial Group?

Oscar Health (NYSE:OSCR) and Principal Financial Group (NASDAQ:PFG) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

Principal Financial Group has higher revenue and earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Principal Financial Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.58-$443.15M-$0.59N/A
Principal Financial Group$15.63B1.44$1.19B$6.9914.86

Oscar Health has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market. Comparatively, Principal Financial Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 75.1% of Principal Financial Group shares are owned by institutional investors. 24.4% of Oscar Health shares are owned by company insiders. Comparatively, 1.1% of Principal Financial Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Principal Financial Group had 7 more articles in the media than Oscar Health. MarketBeat recorded 17 mentions for Principal Financial Group and 10 mentions for Oscar Health. Oscar Health's average media sentiment score of 0.58 beat Principal Financial Group's score of 0.16 indicating that Oscar Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
3 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Principal Financial Group
4 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Oscar Health currently has a consensus target price of $18.22, indicating a potential downside of 19.61%. Principal Financial Group has a consensus target price of $98.10, indicating a potential downside of 5.54%. Given Principal Financial Group's stronger consensus rating and higher probable upside, analysts clearly believe Principal Financial Group is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17
Principal Financial Group
1 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.18

Principal Financial Group has a net margin of 10.10% compared to Oscar Health's net margin of -0.30%. Principal Financial Group's return on equity of 16.25% beat Oscar Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health-0.30% -3.26% -0.57%
Principal Financial Group 10.10%16.25%0.57%

Summary

Principal Financial Group beats Oscar Health on 12 of the 17 factors compared between the two stocks.

How does Oscar Health compare to Aegon?

Oscar Health (NYSE:OSCR) and Aegon (NYSE:AEG) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 4.3% of Aegon shares are owned by institutional investors. 24.4% of Oscar Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Oscar Health presently has a consensus price target of $18.22, indicating a potential downside of 19.61%. Aegon has a consensus price target of $10.00, indicating a potential upside of 16.21%. Given Aegon's stronger consensus rating and higher possible upside, analysts plainly believe Aegon is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17
Aegon
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.63

Aegon has lower revenue, but higher earnings than Oscar Health. Aegon is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.58-$443.15M-$0.59N/A
Aegon$10.29B1.68$1.11B-$0.16N/A

In the previous week, Oscar Health had 9 more articles in the media than Aegon. MarketBeat recorded 10 mentions for Oscar Health and 1 mentions for Aegon. Oscar Health's average media sentiment score of 0.58 beat Aegon's score of 0.33 indicating that Oscar Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
3 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aegon
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Aegon has a net margin of 0.00% compared to Oscar Health's net margin of -0.30%. Aegon's return on equity of 0.00% beat Oscar Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health-0.30% -3.26% -0.57%
Aegon N/A N/A N/A

Oscar Health has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market. Comparatively, Aegon has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

Summary

Aegon beats Oscar Health on 9 of the 16 factors compared between the two stocks.

How does Oscar Health compare to Brookfield Wealth Solutions?

Brookfield Wealth Solutions (NYSE:BNT) and Oscar Health (NYSE:OSCR) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

In the previous week, Oscar Health had 10 more articles in the media than Brookfield Wealth Solutions. MarketBeat recorded 10 mentions for Oscar Health and 0 mentions for Brookfield Wealth Solutions. Oscar Health's average media sentiment score of 0.58 beat Brookfield Wealth Solutions' score of 0.00 indicating that Oscar Health is being referred to more favorably in the news media.

Company Overall Sentiment
Brookfield Wealth Solutions Neutral
Oscar Health Positive

Brookfield Wealth Solutions has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market. Comparatively, Oscar Health has a beta of 2.34, meaning that its stock price is 134% more volatile than the broader market.

20.3% of Brookfield Wealth Solutions shares are owned by institutional investors. Comparatively, 75.7% of Oscar Health shares are owned by institutional investors. 1.0% of Brookfield Wealth Solutions shares are owned by company insiders. Comparatively, 24.4% of Oscar Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Oscar Health has a consensus price target of $18.22, suggesting a potential downside of 19.61%. Given Oscar Health's stronger consensus rating and higher probable upside, analysts plainly believe Oscar Health is more favorable than Brookfield Wealth Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Brookfield Wealth Solutions
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Oscar Health
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17

Brookfield Wealth Solutions has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Brookfield Wealth Solutions, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brookfield Wealth Solutions$10.52B1.46$766M$0.25181.68
Oscar Health$11.70B0.58-$443.15M-$0.59N/A

Brookfield Wealth Solutions has a net margin of 0.16% compared to Oscar Health's net margin of -0.30%. Brookfield Wealth Solutions' return on equity of 0.10% beat Oscar Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Brookfield Wealth Solutions0.16% 0.10% 0.01%
Oscar Health -0.30%-3.26%-0.57%

Summary

Oscar Health beats Brookfield Wealth Solutions on 10 of the 17 factors compared between the two stocks.

How does Oscar Health compare to Everest Group?

Oscar Health (NYSE:OSCR) and Everest Group (NYSE:EG) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Everest Group has a net margin of 11.76% compared to Oscar Health's net margin of -0.30%. Everest Group's return on equity of 14.70% beat Oscar Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health-0.30% -3.26% -0.57%
Everest Group 11.76%14.70%3.63%

Everest Group has higher revenue and earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Everest Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.58-$443.15M-$0.59N/A
Everest Group$17.50B0.80$1.59B$49.177.17

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 92.6% of Everest Group shares are owned by institutional investors. 24.4% of Oscar Health shares are owned by insiders. Comparatively, 0.7% of Everest Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Everest Group had 13 more articles in the media than Oscar Health. MarketBeat recorded 23 mentions for Everest Group and 10 mentions for Oscar Health. Oscar Health's average media sentiment score of 0.58 beat Everest Group's score of 0.42 indicating that Oscar Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
3 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Everest Group
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Oscar Health presently has a consensus price target of $18.22, indicating a potential downside of 19.61%. Everest Group has a consensus price target of $373.73, indicating a potential upside of 5.94%. Given Everest Group's stronger consensus rating and higher probable upside, analysts clearly believe Everest Group is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17
Everest Group
0 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.29

Oscar Health has a beta of 2.34, suggesting that its stock price is 134% more volatile than the broader market. Comparatively, Everest Group has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market.

Summary

Everest Group beats Oscar Health on 13 of the 17 factors compared between the two stocks.

Get Oscar Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSCR vs. The Competition

MetricOscar HealthINS IndustryFinance SectorNYSE Exchange
Market Cap$6.68B$21.34B$13.57B$23.07B
Dividend YieldN/A2.96%5.82%4.09%
P/E Ratio-38.4210.4723.9530.66
Price / Sales0.581.56150.5024.56
Price / CashN/A11.2220.2825.15
Price / Book4.102.182.154.73
Net Income-$443.15M$1.86B$1.13B$1.07B
7 Day Performance-2.59%0.74%0.87%1.95%
1 Month Performance37.99%0.64%-0.02%0.85%
1 Year Performance60.31%3.57%12.00%28.44%

Oscar Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSCR
Oscar Health
3.2893 of 5 stars
$22.67
+2.4%
$18.22
-19.6%
+57.9%$6.68B$11.70BN/A2,305
WTW
Willis Towers Watson Public
4.9388 of 5 stars
$249.72
-2.6%
$352.00
+41.0%
-16.4%$23.59B$9.71B14.5646,900
PFG
Principal Financial Group
3.6521 of 5 stars
$100.19
-0.3%
$95.33
-4.8%
N/A$21.64B$15.63B14.3311,600
AEG
Aegon
3.2492 of 5 stars
$8.42
+1.3%
$10.00
+18.8%
+23.5%$16.88B$10.29BN/A15,304
BNT
Brookfield Wealth Solutions
1.0606 of 5 stars
$46.22
-1.6%
N/A+18.8%$15.62B$11.42B192.594,000

Related Companies and Tools


This page (NYSE:OSCR) was last updated on 5/23/2026 by MarketBeat.com Staff.
From Our Partners